(MedPage Today) — The FDA has expanded the approval of belzutifan (Welireg) to include certain types of pheochromocytoma or paraganglioma (PPGL) in adults and children.
The action establishes belzutifan as the only approved oral therapy for PPGL…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/115582
Author :
Publish date : 2025-05-14 20:17:00
Copyright for syndicated content belongs to the linked Source.
